Patents by Inventor MSD Oss B.V.

MSD Oss B.V. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTISOLVENT SOLIDIFICATION PROCESS
    Publication number: 20130131029
    Abstract: The present invention relates to a antisolvent solidification process wherein a liquid medium comprising at least one organic or inorganic compound which is to be solidified is forced through a membrane into one or more antisolvents, or wherein one or more antisolvents are forced through a membrane into a liquid medium comprising at least one organic or inorganic compound which is to be solidified, yielding a composition comprising solid particles comprising said organic and/or inorganic compound(s).
    Type: Application
    Filed: January 9, 2013
    Publication date: May 23, 2013
    Applicant: MSD Oss B.V.
    Inventor: MSD Oss B.V.
  • DRUG DELIVERY SYSTEM
    Publication number: 20130115265
    Abstract: The subject invention provides a drug delivery system comprising at least one compartment consisting of (i) a drug-loaded thermoplastic polymer core, (ii) a drug-loaded thermoplastic polymer intermediate layer and (iii) a non-medicated thermoplastic polymer skin covering the intermediate layer, wherein said intermediate layer is loaded with (a) crystals of a first pharmaceutically active compound and with (b) a second pharmaceutically active compound in dissolved form and wherein said core is loaded with said second compound in dissolved form.
    Type: Application
    Filed: November 9, 2012
    Publication date: May 9, 2013
    Applicant: MSD Oss B.V.
    Inventor: MSD Oss B.V.
  • ANTIBODIES TO HUMAN PROGRAMMED DEATH RECEPTOR PD-1
    Publication number: 20130109843
    Abstract: Antibodies which block binding of hPD-1 to hPD-L1 or hPD-L2 and their variable region sequences are disclosed. A method of increasing the activity (or reducing downmodulation) of an immune cell through the PD-1 pathway is also disclosed.
    Type: Application
    Filed: December 19, 2012
    Publication date: May 2, 2013
    Applicant: MDS OSS B.V.
    Inventor: MSD OSS B.V.
  • ANTIBODIES TO HUMAN PROGRAMMED DEATH RECEPTOR PD-1
    Publication number: 20130108651
    Abstract: Antibodies which block binding of hPD-1 to hPD-L1 or hPD-L2 and their variable region sequences are disclosed. A method of increasing the activity (or reducing downmodulation) of an immune cell through the PD-1 pathway is also disclosed.
    Type: Application
    Filed: December 19, 2012
    Publication date: May 2, 2013
    Applicant: MSD OSS B.V.
    Inventor: MSD OSS B.V.
  • DRUG DELIVERY SYSTEM
    Publication number: 20130078286
    Abstract: The subject invention provides a drug delivery system comprising at least one compartment consisting of (i) a drug-loaded thermoplastic polymer core, (ii) a drug-loaded thermoplastic polymer intermediate layer and (iii) a non-medicated thermoplastic polymer skin covering the intermediate layer, wherein said intermediate layer is loaded with (a) crystals of a first pharmaceutically active compound and with (b) a second pharmaceutically active compound in dissolved form and wherein said core is loaded with said second compound in dissolved form.
    Type: Application
    Filed: November 9, 2012
    Publication date: March 28, 2013
    Applicant: MSD Oss B.V.
    Inventor: MSD Oss B.V.